CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Gennex Laboratories Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Gennex Laboratories Ltd
Akash Ganga 3rd Floor
Plot No 144, Srinagar Colony
Phone: +91 4067334400p:+91 4067334400 HYDERABAD, 500073  India Ticker: 531739531739

Business Summary
Gennex Laboratories Limited is an integrated pharmaceutical company and has a product portfolio spread over various product segments encompassing expectorants, muscle relaxants, analgesic and anti-fungal. The Company is engaged in manufacturing of bulk drugs, intermediates and biotech products. It operates through Pharmaceutical Products segment. Its products include active pharmaceutical ingredients (APIs), such as Guaifenesin USP/BP/EP/IP, which is an expectorant, (mucolyte); Methocarbamol USP, which is a relaxant (skeletal muscle relaxant); Phenazopyridine Hcl USP, which is an urinary tract analgesic; Fluconazole EP/USP, which is an anti-fungal product; Metformin Hcl IP/BP, which is an anti-diabetic product; Ambroxol Hcl IP/BP, which is an expectorant, (mucolyte), and Melitracen Hcl, which is an antidepressant and anxiolytic. The Company intends to offers other APIs, such as Flupentixol DIHCL BP, Domperidone BP/EP, Mephenesin BP, Mefanemic Acid USP/BP/IP and Chlorophenesin USP/BP.

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
IRA CQ
Score
Moody's
Rating
Fitch
Rating
DBRS
Rating
Morningstar
Rating
YesYes-------

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
9/30/20193/31/2019Yes----

Industries
SIC Code Description
2833 Medicinal chemicals and botanical products

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Chief Operating Officer, Compliance Officer K. V.Bhaswanth
Managing Director, Director ArihantBaid 5/18/2012 5/18/2012
Whole Time Director Tiruvarur M.Gopalakrishnan 5/18/2012 5/18/2012
3 additional Officers and Directors records available in full report.

Business Names
Business Name
531739
Gennex Laboratories Ltd

General Information
Outstanding Shares: 126,503,000 (As of 9/30/2019)
Shareholders: 5,731
Stock Exchange: BOM
Fax Number: +91 4067334401


Copyright © 2019 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, December 06, 2019